Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Esterline Technologies was a global manufacturer of highly engineered products primarily for the aerospace and defense industries, with a significant specialized presence in the medical device market. The company's healthcare business focused on human-machine interface (HMI) solutions, including medical-grade keyboards, displays, and control panels used in surgical suites and diagnostic imaging. These products were designed for high reliability and compliance with strict medical sterilization standards, often operating under the Esterline Interface Technologies brand. In March 2019, the company was acquired by TransDigm Group for approximately $4 billion and subsequently delisted from the NYSE.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Esterline Technologies.